At5g16150 Antibody is a polyclonal antibody raised against the Arabidopsis thaliana gene product At5g16150, a plastidic glucose transporter (pGlcT) involved in carbohydrate metabolism . This antibody specifically recognizes the At5g16150 protein (UniProt ID: Q9LZ05), also designated as Glucose Transporter 1 (GLT1) or Plastidic Glucose Translocator 1 (pGlcT1), which facilitates glucose transport across chloroplast membranes .
This antibody has been utilized in:
Western Blot (WB): Detects ~55 kDa band corresponding to pGlcT1 in Arabidopsis leaf extracts .
ELISA: Quantifies pGlcT1 expression under varying metabolic conditions .
Proteomic Studies: Identified altered accumulation in apg (albino or pale green) mutants, revealing its role in chloroplast development .
Table 1: Protein accumulation changes in apg mutants (normalized spectral counts) :
| Genotype | At5g16150 Level | Wild Type Level | Fold Change |
|---|---|---|---|
| apg1 | 0.00 | 0.04 | 0x |
| apg2 | 0.08 | 0.04 | 2x |
| apg3 | 0.17 | 0.04 | 4.25x |
Chloroplast Metabolic Regulation: At5g16150 knockdown mutants exhibit reduced UDP-glucose levels, impairing nucleotide sugar metabolism and chloroplast function .
Stress Responses: pGlcT1 accumulation decreases under phosphate limitation, linking glucose transport to stress adaptation .
Protein Interaction Networks: Co-purifies with TIC21 (Translocon at Inner Chloroplast membrane 21) and TOC34 (Translocon at Outer Chloroplast membrane 34), indicating roles in protein import machinery .
At5g16150 participates in:
Carbon Partitioning: Mediates glucose flux into chloroplasts for starch biosynthesis .
Nucleotide Metabolism: Regulates UDP-glucose pools critical for cell wall synthesis .
Stress Signaling: Modulates redox balance through interactions with plastidic NADPH dehydrogenases .
At5g16150 is an Arabidopsis thaliana gene encoding a plastidic glucose transporter (PGLCT/GLT1) that facilitates glucose movement between cytosol and plastids . This protein is essential for understanding plant carbon partitioning, energy metabolism, and plastid function. Studying At5g16150 provides critical insights into photosynthate allocation and utilization, processes fundamental to plant growth, development, and stress responses.
The primary antibody available is a rabbit polyclonal antibody against Arabidopsis thaliana At5g16150, generated through antigen-affinity purification . This polyclonal antibody recognizes multiple epitopes on the target protein, potentially enhancing detection sensitivity. The antibody is raised using recombinant protein approaches rather than synthetic peptides, as recombinant protein methods have demonstrated significantly higher success rates (55% versus very low for peptide approaches) in generating effective plant protein antibodies .
Rigorous validation is critical when working with plant protein antibodies. Essential validation approaches include:
Genetic validation using at5g16150 null mutants as negative controls
Western blot analysis confirming the presence of a single band of expected molecular weight (~55-60 kDa)
Immunolocalization studies showing absence of signal in mutant backgrounds
Pre-adsorption tests with the immunizing antigen to demonstrate signal elimination
Correlation of protein detection with known expression patterns
Studies from large-scale antibody production initiatives have demonstrated that antibodies validated against mutant backgrounds consistently show no detectable signal in corresponding mutant lines, confirming specificity .
Recombinant protein-based antibodies demonstrate superior performance compared to peptide-based antibodies for plant proteins like At5g16150. Evidence shows:
Recombinant protein approaches yield significantly higher success rates (55% detection rate) versus peptide-based methods (<5% success rate)
Peptide antibodies frequently fail to recognize native protein conformations
Recombinant protein antibodies recognize multiple epitopes, improving detection probability
Affinity purification dramatically improves detection rates for recombinant protein antibodies
For membrane proteins like transporters, recombinant protein antibodies better recognize conformational epitopes
Research has shown that despite good antibody titers on dot blots, most crude antisera fail in complex applications, making affinity purification essential for reliable detection .
For successful Western blot detection of At5g16150:
Sample preparation:
Extract total protein using buffer containing 1% Triton X-100 or 0.5% SDS to solubilize membrane-associated proteins
Include protease inhibitor cocktail to prevent degradation
Use fresh samples whenever possible to minimize degradation
Electrophoresis considerations:
Separate proteins on 10-12% SDS-PAGE
Load 30-50 μg total protein per lane
Include wild-type and at5g16150 mutant samples as controls
Immunodetection:
Block with 5% non-fat milk in TBST
Dilute affinity-purified At5g16150 antibody 1:1000 to 1:5000
Incubate overnight at 4°C for optimal sensitivity
Use HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000)
Develop using enhanced chemiluminescence
Anticipated results:
Expected band size: approximately 55-60 kDa
No bands should appear in null mutant samples
Minimize non-specific background by optimizing antibody dilution
Affinity purification against the recombinant protein significantly improves detection success rates compared to crude antisera .
For optimal immunolocalization of At5g16150 in plant tissues:
Tissue fixation and preparation:
Fix tissues in 4% paraformaldehyde in PBS (pH 7.4) for 1-2 hours
For roots, consider whole-mount preparation for structural context preservation
For leaves, prepare 5-10 μm sections after paraffin or resin embedding
Include both wild-type and at5g16150 mutant tissues as controls
Immunostaining procedure:
Permeabilize with 0.1-0.5% Triton X-100 (optimize for membrane proteins)
Block with 3-5% BSA containing 0.1% Triton X-100 for 1-2 hours
Incubate with affinity-purified At5g16150 antibody (1:50-1:200 dilution) overnight at 4°C
Wash extensively with PBS containing 0.1% Tween-20
Apply fluorescently-labeled secondary antibody (1:500) for 2 hours
Counterstain nuclei with DAPI
Signal detection optimization:
Use confocal microscopy with appropriate filter sets
Adjust laser intensity and gain to avoid saturation
Collect z-stack images to analyze three-dimensional distribution
Apply identical imaging parameters when comparing wild-type and mutant samples
Research has demonstrated that crude antisera rarely produce detectable signals in immunolocalization studies, with affinity purification being essential for successful detection .
Researchers should anticipate and address these common technical challenges:
Weak or absent signal:
Non-specific background:
Optimize blocking conditions (try different blockers: BSA, milk, normal serum)
Increase washing stringency (higher salt concentration, longer washing)
Pre-adsorb antibody with total protein from at5g16150 mutant
Dilute antibody in blocking solution containing 0.1% Tween-20
Unexpected band patterns:
Verify sample integrity with fresh extractions
Include protease inhibitors to prevent degradation
Compare with published literature on expected patterns
Validate bands through peptide competition assays
Inconsistent results:
Standardize protein extraction and quantification methods
Maintain consistent antibody dilutions and incubation times
Use internal controls for normalization
Prepare larger antibody aliquots to minimize freeze-thaw cycles
The CPIB antibody project demonstrated that affinity purification dramatically improved detection rates from near zero to over 50% for plant protein antibodies .
For rigorous quantitative analysis using At5g16150 antibody:
Essential experimental controls:
Technical replicates (minimum triplicate) for each biological sample
Biological replicates (minimum n=3) from independent plant populations
Positive control (wild-type tissue expressing At5g16150)
Negative control (at5g16150 null mutant tissue)
Loading control (constitutively expressed protein like actin or tubulin)
Standard curve calibration:
Include serial dilutions of samples to ensure measurements within linear range
Consider using purified recombinant protein standards for absolute quantification
Generate standard curves with each experimental run
Normalization strategies:
Normalize to total protein (determined by stain-free technology or Ponceau S)
Use multiple reference proteins for more reliable normalization
Apply global normalization methods when analyzing multiple proteins
Statistical validation:
Calculate coefficient of variation between technical replicates (<10% for reliable quantification)
Apply appropriate statistical tests based on experimental design
Report confidence intervals alongside mean values
Present raw data alongside normalized results
Validation against genetic backgrounds remains the gold standard for antibody specificity confirmation, as demonstrated in comprehensive antibody testing programs .
To elucidate glucose transport mechanisms using At5g16150 antibody:
Subcellular localization approaches:
Perform high-resolution immunogold electron microscopy to precisely localize At5g16150 within chloroplast membrane subdomains
Use double immunolabeling with other chloroplast marker proteins
Correlate transporter distribution with functional domains of the chloroplast envelope
Analyze distribution patterns under different metabolic conditions
Biochemical fractionation strategy:
Isolate intact chloroplasts through Percoll gradient centrifugation
Further fractionate into envelope, stroma, and thylakoid components
Perform Western blotting to quantify At5g16150 enrichment in specific fractions
Compare protein distribution with transport activity measurements
Structure-function analysis:
Combine antibody detection with site-directed mutagenesis of key residues
Correlate protein abundance with transport activity measurements
Study transporter topology using protease protection assays
Investigate oligomerization state through native PAGE and immunodetection
Environmental response studies:
Monitor protein redistribution under varying light/dark conditions
Quantify transporter abundance during sugar starvation/feeding
Analyze post-translational modifications under different metabolic states
These approaches align with methodologies successfully employed for other plastid membrane proteins in large-scale antibody characterization projects .
To investigate protein-protein interactions involving At5g16150:
Co-immunoprecipitation methodology:
Solubilize membranes using gentle detergents (0.5-1% digitonin or n-dodecyl-β-D-maltoside)
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Immunoprecipitate with affinity-purified At5g16150 antibody
Identify co-precipitating proteins through mass spectrometry
Validate interactions through reverse co-IP with antibodies against interacting partners
Proximity-based approaches:
Implement proximity ligation assay (PLA) to visualize interactions in situ
Use split-GFP complementation verified with antibody detection
Employ BioID or APEX2 proximity labeling with antibody validation
Complex analysis techniques:
Analyze protein complexes through blue native PAGE followed by immunoblotting
Perform sucrose gradient fractionation to separate complexes by size
Use chemical crosslinking prior to immunoprecipitation to stabilize transient interactions
Dynamic interaction studies:
Monitor interaction changes during developmental progression
Analyze complex formation under different metabolic states
Study interaction kinetics following environmental stimuli
Affinity-purified antibodies significantly improve detection specificity in complex applications like protein interaction studies, as demonstrated by the CPIB antibody project .
To establish correlations between At5g16150 protein abundance and transport function:
Quantitative experimental design:
Measure protein levels by quantitative Western blotting across:
Different tissues and developmental stages
Environmental conditions affecting glucose metabolism
Genetic backgrounds with altered transport activity
In parallel, quantify glucose transport using:
Radiolabeled glucose uptake assays with isolated chloroplasts
Fluorescent glucose analog transport measurements
Metabolomic profiling of glucose levels in different compartments
Inducible expression systems:
Generate plants with inducible At5g16150 expression
Quantify protein accumulation timing using the antibody
Correlate with concurrent measurements of transport activity
Perform time-course analysis to establish causality
Structure-function correlation:
Analyze mutant proteins with altered transport properties
Quantify protein levels using the antibody
Calculate specific activity (transport rate per unit protein)
Identify domains essential for function versus stability
In situ correlation approaches:
Combine immunolocalization with functional glucose sensors
Perform cell-type specific analysis of transport activity
Correlate expression patterns with tissue-specific glucose dynamics
This multifaceted approach provides robust evidence linking protein abundance to functional activity, a strategy successfully employed for other transporters in comprehensive antibody studies .
To address potential cross-reactivity with related glucose transporters:
Epitope selection and antibody design:
Rigorous validation approach:
Test antibody against tissues from knockout mutants of the target gene
Perform peptide competition assays with the immunizing antigen
Evaluate cross-reactivity against recombinant proteins of related family members
Compare detection patterns with transcriptional data
Technical optimization:
Increase antibody dilution to reduce low-affinity cross-reactive binding
Optimize washing stringency to eliminate weak cross-reactions
Use pre-adsorption with extracts from knockout plants
Complementary approaches:
Combine antibody studies with epitope-tagged versions of the protein
Use gene-specific knockdown to correlate with protein detection levels
Implement CRISPR-based tagging for endogenous protein detection
The CPIB antibody project successfully implemented a 40% sequence similarity threshold for minimizing cross-reactivity while maintaining sufficient antigen size for antibody production .
For robust quantification of At5g16150 protein:
Experimental design for statistical validity:
Minimum three biological replicates (independent plant populations)
Technical triplicates for each biological sample
Include serial dilutions to confirm linear detection range
Design balanced experiments with appropriate controls
Quantification methodology:
Use digital imaging systems with broad dynamic range
Perform background subtraction using adjacent blank areas
Define consistent region of interest for all samples
Normalize to loading controls (e.g., actin, tubulin, or total protein)
Statistical analysis framework:
Test data for normality using Shapiro-Wilk or Kolmogorov-Smirnov tests
For comparison of two groups: Student's t-test (parametric) or Mann-Whitney U test (non-parametric)
For multiple groups: One-way ANOVA with post-hoc tests (Tukey's HSD)
For complex designs: Two-way ANOVA for evaluating interaction effects
Data presentation standards:
Report means with standard error or 95% confidence intervals
Present normalized values alongside representative blot images
Include statistical significance indicators with exact p-values
Provide sample size and replication information
| Experimental Comparison | Recommended Test | Sample Size | Validation Method |
|---|---|---|---|
| Two conditions | Student's t-test | n≥3 biological replicates | Normality testing |
| Multiple treatments | One-way ANOVA with Tukey's HSD | n≥4 biological replicates | Homogeneity of variance |
| Two factors | Two-way ANOVA | n≥4 biological replicates | Interaction plot analysis |
| Time-course analysis | Repeated measures ANOVA | n≥3 biological replicates | Sphericity testing |
When encountering unexpected Western blot band patterns:
Systematic pattern analysis:
Document precise molecular weights of all observed bands
Compare with predicted size based on amino acid sequence (approximately 55-60 kDa)
Evaluate consistency across multiple experiments and tissue types
Check for patterns coinciding with known splice variants or processing events
Biological explanation assessment:
Post-translational modifications (phosphorylation, glycosylation) may alter migration
Proteolytic processing could generate specific fragments
Protein complexes resistant to denaturation may appear as higher molecular weight bands
Alternative transcription start sites or splice variants may produce size variants
Technical troubleshooting:
Compare fresh samples with stored extracts to identify degradation patterns
Test different extraction buffers to optimize protein solubilization
Vary denaturation conditions (temperature, detergent concentration)
Perform peptide competition assay to identify which bands are specific
Validation approaches:
Compare band patterns in wild-type versus knockout/knockdown plants
Check patterns across different tissues with known expression differences
Use alternative antibodies targeting different epitopes if available
Correlate with patterns reported in published literature
Similar observations in the CPIB antibody project revealed that even well-characterized antibodies sometimes detect unexpected band patterns that may reflect biological phenomena rather than technical issues .
To enhance detection of low-abundance At5g16150:
Sample optimization strategies:
Enrich for membrane fractions containing the target protein
Select tissues/conditions with highest expression levels
Concentrate proteins through TCA precipitation or similar methods
Use optimized extraction buffers for membrane proteins (containing appropriate detergents)
Detection enhancement techniques:
Implement extended primary antibody incubation (overnight at 4°C)
Use high-sensitivity ECL substrates (femtomolar detection range)
Utilize signal amplification systems like tyramide signal amplification (TSA)
Apply poly-HRP conjugated secondary antibodies for signal boosting
Imaging optimization:
Extend exposure times within linear detection range
Use cooled CCD cameras for high sensitivity, low-noise imaging
Apply background subtraction algorithms during image analysis
Consider signal averaging across multiple exposures
Alternative detection methods:
Immunoprecipitate protein prior to Western blotting
Use capillary Western systems for higher sensitivity
Consider MS-based targeted proteomics for extremely low abundance
Implement ELISA-based quantification where appropriate
Affinity purification of antibodies has been demonstrated to significantly improve detection sensitivity compared to crude antisera, particularly for low-abundance proteins .
To differentiate between changes in protein levels versus activity:
Comprehensive experimental design:
Measure protein abundance through quantitative immunoblotting
Concurrently assess glucose transport activity in identical samples
Calculate specific activity (transport rate per unit protein)
Analyze transport kinetics (Km and Vmax) to identify regulatory mechanisms
Post-translational modification analysis:
Combined immunoprecipitation and mass spectrometry to identify modifications
Use phospho-specific antibodies if phosphorylation is suspected
Compare gel migration patterns under conditions affecting activity
Correlate modifications with transport activity changes
Protein interaction studies:
Identify regulatory protein interactions under different activity states
Analyze changes in protein complex formation using native PAGE
Correlate interaction patterns with activity measurements
Test effects of disrupting specific interactions
Subcellular localization assessment:
Analyze transporter redistribution between active and inactive states
Quantify protein levels in different membrane compartments
Correlate localization changes with activity measurements
Consider trafficking mechanisms affecting functional pool size
| Parameter | Measurement Method | Expected Outcome: Expression Change | Expected Outcome: Activity Regulation |
|---|---|---|---|
| Protein level | Quantitative immunoblot | Significant change | No change or minimal change |
| mRNA level | qRT-PCR | Correlates with protein change | No correlation with activity change |
| Transport activity | Glucose uptake assay | Proportional to protein level | Changes independent of protein level |
| PTMs | Phospho-antibodies/MS | No significant change | Modified in correlation with activity |
| Protein interactions | Co-IP or PLA | Similar interaction partners | Different interaction patterns |
| Subcellular location | Immunolocalization | Similar distribution pattern | Redistribution correlating with activity |
For integrating At5g16150 antibody into multi-omics frameworks:
Proteomics integration strategies:
Use antibody for validation of mass spectrometry-based proteomics data
Apply immunoprecipitation coupled with MS for studying protein complexes
Implement targeted proteomics with parallel reaction monitoring for absolute quantification
Validate post-translational modifications identified in global proteomics
Transcriptomics correlation:
Compare protein levels (immunoblot) with transcript abundance (RNA-seq)
Identify discordances suggesting post-transcriptional regulation
Analyze correlation patterns across developmental stages and conditions
Create integrated models of transcriptional and translational regulation
Metabolomics linkage:
Correlate At5g16150 protein levels with glucose and related metabolite concentrations
Construct pathway models incorporating transporter abundance data
Design perturbation experiments to test causal relationships
Develop predictive models of metabolite flux based on transporter abundance
Systems biology framework:
Position antibody data in multi-layer regulatory networks
Implement mathematical modeling incorporating protein abundance data
Validate model predictions through targeted experiments
Develop visualization tools for integrated data representation
| Omics Layer | Technology | At5g16150 Antibody Role | Integration Approach |
|---|---|---|---|
| Proteomics | LC-MS/MS | Validation, enrichment | Correlation analysis, targeted verification |
| Transcriptomics | RNA-seq | Post-transcriptional regulation | Protein-mRNA correlation, splicing analysis |
| Metabolomics | GC-MS/LC-MS | Linking protein to metabolites | Pathway flux analysis, transport modeling |
| Interactomics | IP-MS | Complex capture, validation | Network construction, dynamics analysis |
| Phenomics | Growth analysis | Linking protein to function | Causality testing, multi-level modeling |
Emerging techniques advancing At5g16150 antibody applications:
Advanced microscopy approaches:
Super-resolution microscopy (STORM, PALM) for nanoscale localization
Expansion microscopy for enhanced spatial resolution in plant tissues
Correlative light and electron microscopy (CLEM) linking function to ultrastructure
Live-cell imaging with complementary fluorescent glucose sensors
Single-cell analysis integration:
Combine antibody-based detection with single-cell isolation techniques
Develop methods for quantitative immunofluorescence in isolated protoplasts
Correlate with single-cell transcriptomics and metabolomics
Map cell-specific transporter variation in complex tissues
Protein dynamics visualization:
Pulse-chase labeling combined with immunoprecipitation
FRAP (Fluorescence Recovery After Photobleaching) with antibody validation
Optogenetic manipulation of transporter activity with antibody monitoring
Microfluidic approaches for real-time monitoring of protein behavior
CRISPR-based applications:
CRISPR activation/repression systems with antibody-based validation
Endogenous protein tagging validated with correlation to antibody signal
Base editing to introduce specific mutations affecting transporter function
Multiplexed CRISPR screening with antibody-based phenotyping
These emerging technologies will significantly expand the applications of plant protein antibodies, building upon the foundation established by comprehensive antibody development programs .
For effective cross-species application of At5g16150 antibody:
Sequence homology analysis:
Perform comprehensive alignment of At5g16150 homologs across target species
Focus specifically on the epitope region used for antibody generation
Calculate percent identity and similarity scores
Predict cross-reactivity based on conservation threshold (>60% identity suggests likely cross-reactivity)
Empirical validation framework:
Test antibody in phylogenetically related species first (within Brassicaceae)
Validate with appropriate controls (genetic knockout where available)
Perform Western blots to confirm expected molecular weight
Complement with transcript analysis of the homologous gene
Technical optimization for cross-species detection:
Modify antibody concentration (typically increase for distant species)
Adjust incubation conditions (longer incubation times for weaker interactions)
Optimize blocking and washing stringency
Consider native versus denaturing conditions for epitope accessibility
Complementary approaches:
Use heterologous expression of the target protein as positive control
Implement epitope tagging of homologous proteins for validation
Consider raising species-specific antibodies for critical applications
Use bioinformatic prediction to identify most conserved epitopes
| Plant Species | % Identity to At5g16150 | Predicted Cross-Reactivity | Recommended Antibody Dilution |
|---|---|---|---|
| Arabidopsis thaliana | 100% | High | 1:1000-1:5000 |
| Brassica species | 80-90% | Good | 1:500-1:2000 |
| Other Brassicaceae | 70-80% | Moderate | 1:200-1:1000 |
| Other dicots | 50-70% | Variable | 1:100-1:500 |
| Monocots | 40-60% | Low | 1:50-1:200 |
| Gymnosperms | <40% | Very low | Not recommended |
To investigate stress responses using At5g16150 antibody:
Stress-induced expression analysis:
Monitor protein levels under various stresses (drought, cold, salt, light, nutrient)
Perform time-course analysis to capture dynamic responses
Compare with transcriptional changes to identify post-transcriptional regulation
Analyze tissue-specific responses through immunolocalization
Subcellular redistribution studies:
Examine stress-induced changes in transporter localization
Quantify protein abundance in different membrane fractions
Correlate redistribution with changes in glucose uptake activity
Investigate mechanisms of transporter trafficking during stress
Post-translational modification analysis:
Identify stress-induced modifications (phosphorylation, ubiquitination)
Isolate the protein by immunoprecipitation for modification analysis
Correlate modifications with changes in activity and localization
Investigate regulatory kinases and phosphatases using inhibitor studies
Protein-protein interaction remodeling:
Compare interaction partners under normal and stress conditions
Identify stress-specific regulatory proteins
Analyze changes in transporter complex formation
Link interaction changes to functional adaptations
These approaches align with methodologies successfully applied to other transporters in comprehensive antibody characterization studies, providing insights into plant adaptation mechanisms .